"Living in a state of nature; not tamed or domesticated."
So after waiting most of the day for the rain to stop
Wednesday, 30 April 2008
Wild
HSMS Prompt for today was...Wild
"Living in a state of nature; not tamed or domesticated."
So after waiting most of the day for the rain to stop
"Living in a state of nature; not tamed or domesticated."
So after waiting most of the day for the rain to stop
Tuesday, 29 April 2008
Monday, 28 April 2008
Friday, 25 April 2008
The Good News Is
My lovely daughter just made me lunchChicken,Mayo and Tomato Sandwich with a handful of juicy green grapes.
Just goes to show students at home studying can be nice.
But the bad news is the weatherman has said it is going to rain.
Twisted
Came across this lovely blog who have a daily photographic challenge, just what i need to get my brain into gear. I hope they don't mind me joining in. Today's prompt is:
"Bent, curly, inter-twined material or warped state of mind. Have you got something twisted in your space?"
Twisted Jasmine stems, when they eventually flo
wer they smell delicious.
"Bent, curly, inter-twined material or warped state of mind. Have you got something twisted in your space?"
Twisted Jasmine stems, when they eventually flo
wer they smell delicious.
Thursday, 24 April 2008
This Knitting Malarky Is Addictive
But I think I should stop calling them Monkees as the latest two are definately a species unknown to man. Meet Molly (Rat Look-A-Likey) and Freddie (Fraggle)
Tuesday, 8 April 2008
Meet Taloola
A Beautiful Baby
She is growing up fast
Perhaps a little too fast
Gemma has claimed this one and tries her best to keep her under control
She is growing up fast
Perhaps a little too fast
Gemma has claimed this one and tries her best to keep her under control
But fails miserably
And if she keeps up this behaviour ( click video) she will be out the door
Thursday, 3 April 2008
ME: 'Invisible disease' is now easier to read
An extract from The Telegraph 18th March
A simple blood test may revolutionise the way we treat patients with ME, reports Bob Ward
British researchers are close to developing, for the first time, a blood test and potential drug treatments for myalgic encephalomyelitis (ME), also known as chronic fatigue syndrome (CFS), following groundbreaking work on its genetic origins. ME/CFS affects about one in 200 people, and women sufferers outnumber men by six to one. It causes a constant feeling of extreme exhaustion and malaise for more than six months, along with sleep abnormalities, memory and concentration difficulties and a great deal of pain.
In its most extreme form, the disease leaves sufferers bed-ridden and can even be fatal.
But patients now have new hope, thanks to research published in the Journal of Clinical Pathology by Dr Jonathan Kerr of St George's University of London and his colleagues.
They have identified 88 genes that produce different levels of proteins and other molecules in ME/CFS sufferers compared with the rest of the population.
Dr Kerr's team carried out a complex analysis of the records of 55 patients and found that they could be divided into seven sub-types according to the specific gene combinations found in their white blood cells, and the severity of their symptoms.
The most acutely affected patients had 71 of the 88 gene abnormalities.
The results of this work should allow better understanding of the causes and development of the disease. Many of the genes are known to be affected when a person contracts a virus, a factor which is believed to trigger many cases of ME/CFS.
Importantly, the researchers also recognised that five of the 88 genes are targeted by drugs which are already used to treat other diseases.
The team is now investigating whether the faulty genes produce abnormal levels of proteins that can be detected as minute quantities of "biomarkers" in the blood of patients.
"If proven to be sensitive and specific indicators of the illness, the discovery of protein biomarkers could lead to the development of a diagnostic test for ME/CFS, which would revolutionise our approach to this disease," explains Dr Kerr.
He will present his results at a conference on ME/CFS biomedical research in Cambridge in May.
A simple blood test may revolutionise the way we treat patients with ME, reports Bob Ward
British researchers are close to developing, for the first time, a blood test and potential drug treatments for myalgic encephalomyelitis (ME), also known as chronic fatigue syndrome (CFS), following groundbreaking work on its genetic origins. ME/CFS affects about one in 200 people, and women sufferers outnumber men by six to one. It causes a constant feeling of extreme exhaustion and malaise for more than six months, along with sleep abnormalities, memory and concentration difficulties and a great deal of pain.
In its most extreme form, the disease leaves sufferers bed-ridden and can even be fatal.
But patients now have new hope, thanks to research published in the Journal of Clinical Pathology by Dr Jonathan Kerr of St George's University of London and his colleagues.
They have identified 88 genes that produce different levels of proteins and other molecules in ME/CFS sufferers compared with the rest of the population.
Dr Kerr's team carried out a complex analysis of the records of 55 patients and found that they could be divided into seven sub-types according to the specific gene combinations found in their white blood cells, and the severity of their symptoms.
The most acutely affected patients had 71 of the 88 gene abnormalities.
The results of this work should allow better understanding of the causes and development of the disease. Many of the genes are known to be affected when a person contracts a virus, a factor which is believed to trigger many cases of ME/CFS.
Importantly, the researchers also recognised that five of the 88 genes are targeted by drugs which are already used to treat other diseases.
The team is now investigating whether the faulty genes produce abnormal levels of proteins that can be detected as minute quantities of "biomarkers" in the blood of patients.
"If proven to be sensitive and specific indicators of the illness, the discovery of protein biomarkers could lead to the development of a diagnostic test for ME/CFS, which would revolutionise our approach to this disease," explains Dr Kerr.
He will present his results at a conference on ME/CFS biomedical research in Cambridge in May.
Wednesday, 2 April 2008
Stevie's Big Cuz
Not put of by Stevie's uniqueness, I persevered and another Monkee was created, he was very chilled out and has now gone to his new home. Word has it that Stevie's Lil Sis is about to make her debut soon, she is gonna be trouble, I can tell, so watch this space
Subscribe to:
Posts (Atom)